The article title "Pharmac's decision over diabetes drugs could see up to 140,000 'miss out', doctor says". Diabetes Foundation Aotearoa Board Chair and South Auckland endocrinologist, Dr John Baker talks to Steve Forbes of the Herald. He asks where the ethics lie as a specialist of deciding who gets the new medications, which can make a major difference to the health of people with type 2 diabetes...and who doesn't.
